PTC Therapeutics | Srodki Pieniężne I Ekwiwalent



Cash And Equivalent Zmiana Data
Acadia Pharmaceuticals USD 755.99M 190.66M 2024-12
Alnylam Pharmaceuticals USD 966.43M 133.49M 2024-12
Amgen USD 11.97B 2.96B 2024-12
Biogen USD 2.38B 675.8M 2024-12
BioMarin Pharmaceutical USD 613.22M 324.54M 2024-12
Cytokinetics USD 94.86M 47.97M 2024-12
Daiichi Sankyo JPY 682.15B 25.52B 2024-12
Gilead Sciences USD 9.99B 4.95B 2024-12
Incyte USD 1.69B 383.72M 2024-12
Ionis Pharmaceuticals USD 242.08M 92.53M 2024-12
Ironwood Pharmaceuticals USD 88.56M 348K 2024-12
Novartis USD 8.87B 4.74B 2024-12
Pfizer USD 1.04B 49M 2024-12
PTC Therapeutics USD 779.71M 253.71M 2024-12
Roche Holding CHF 6.98B 2.15B 2024-12
Sarepta Therapeutics USD 1.1B 905.16M 2024-12
TG Therapeutics USD 179.89M 15.93M 2024-12
Ultragenyx Pharmaceutical USD 173.73M 23.11M 2024-12
Vertex Pharmaceuticals USD 4.57B 669.6M 2024-12
Xencor USD 40.88M 11.84M 2024-12



PTC Therapeutics Srodki Pieniężne I Ekwiwalent - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Apr 2025.